Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy.
Sign Up to like & getrecommendations! Published in 2020 at "Current opinion in immunology"
DOI: 10.1016/j.coi.2020.03.004
Abstract: Immune-targeted approaches are rapidly changing the therapeutic landscape for cancer. In spite of that, most patients show resistance or acquire resistance to these therapies. Increasing work describing the tumor microenvironment (TME) has highlighted this space… read more here.
Keywords: key determinants; immunotherapy; associated fibroblasts; determinants tumor ... See more keywords